The nation of Zimbabwe has rejected a significant US health deal valued at $367m (272 million pounds) over five years due to the United States' insistence on sensitive biological samples.
This rejection was revealed after a government memo from December was disclosed, revealing that Head of State Emmerson Mnangagwa believed the deal was "unbalanced".
An official spokesperson has since stated that the US was requesting genetic material for scientific study and profit while was not willing to guarantee the resulting advantages from any future treatments.
"We are forced to start the difficult and regrettable task of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the US had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for further talks to reach a deal agreeable to all parties so the country's vital HIV programme can continue.
Broader Implications
Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a high court blocked a similar deal with the US following legal challenges were raised about the security of Kenyans' health data.
After returning to office last year, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had managed assistance for the American government, but Trump argued its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to boost openness and responsibility.
Based on statements, Sixteen African countries have so far signed similar health pacts, constituting over $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, with no corresponding guarantee of access to any medical innovations – such as new medicines or tests – that might be developed from that provided information," Mangwana explained.
"In essence, our nation would provide the basic resources for medical research without any certainty that the final treatments would be accessible to our population if a new disease outbreak emerge."
Sovereignty and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining systems already set up via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to deal with potential pandemics.
"This framework is designed to ensure that when a country contributes its data, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to create them."
The government's concerns over the US deal "are not meant as anti-American sentiment," he added.
"We are open to continued discussions with our American counterparts on how subsequent co-operation could be structured in a way that honours the independence and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but suggested that negotiations must proceed considering much of the country's HIV programmes were funded by foreign aid.
"In cases where specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be resolved through technical clarification and negotiated safeguards," it said.
The halted deal underscores the continuing tensions between accepting much-needed international aid and safeguarding local interests in an increasingly interconnected world.